EP Patent

EP3229824A4 — Oral octreotide administered in combination with other therapeutic agents

Assigned to GELBAUM, DANA · Expires 2018-07-11 · 8y expired

What this patent protects

Patent listed against octreotide-acetate.

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: EP3229824A4
Jurisdiction: EP
Classification: —
Expires: 2018-07-11
Drug substance claim: No
Drug product claim: No
Assignee: GELBAUM, DANA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.